Significant tumour response to neoadjuvant therapy in high-risk non-metastatic prostate cancer Presented ByProf. Neil Fleshner, Princess Margaret Cancer Centre, Canada TrialPhase 2, ACDC-RP ConferenceASCO GU 2022 TypePeer-reviewed article 8 April 2022 11:22